Table 2.
Frequency at which various preventability factors were observed amongst 69 ADRs considered to have contributed to the death of 56 patients
| Schumock & Thornton criteria | Number of occurrences |
|---|---|
| Was the drug involved in the ADR not considered appropriate for the patient’s clinical condition based on published guidelines, clinical studies, abstracts, case reports, case series? | 16 |
| Was the dose, route and frequency of administration not appropriate for the patient’s age, weight, or disease state (e.g. renal/hepatic function) based on published literature (e.g. South African Medicines Formulary, MIMS) | 5 |
| Was required therapeutic drug monitoring or other laboratory test not performed? | 11 |
| Was there a history of allergy or previous reaction to the drug? | 0 |
| Was a drug interaction involved in the reaction? | 4 |
| Was the serum drug concentration above the therapeutic range documented in adults? | 0 |
| Did compliance possibly contribute to the reaction? | 2 |
ADR, adverse drug reaction.